Modus Therapeutics completes venture financing

On Feb. 20, sickle cell disease play Modus Therapeutics AM (Stockholm, Sweden) raised SEK32 million ($3.6 million) in a venture round with existing investors KDev Investments, Östersjöstiftelsen and P...